| |
| |
|
| Insider
Information: |
Andreotti Lamberto |
| Relationship: |
|
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,011,868 |
|
|
Indirect Shares
|
241,273 |
|
|
| Direct
Value |
$43,897,661 |
|
|
|
Indirect Value
|
$10,666,679 |
|
|
| Total
Shares |
1,253,141 |
|
|
| Total
Value |
$54,564,340 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 14.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Director |
2017-04-07 |
935,571 |
2017-04-07 |
241,273 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2009-12-23 |
19,609 |
2009-02-17 |
0 |
Premium* |
|
|
DuPont de Nemours Inc |
DD |
Director |
2017-08-31 |
0 |
2012-08-02 |
0 |
Premium* |
|
|
Dowdupont Inc. |
DWDP |
Director |
2019-05-21 |
22,231 |
|
0 |
Premium* |
|
|
Corteva, Inc. |
CTVA |
|
2024-04-26 |
34,457 |
2019-06-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
218 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 9
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DWDP |
Dowdupont Inc. |
Director |
– • – |
2017-09-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
18,263 |
|
- |
|
| CTVA |
Corteva, Inc. |
Director |
– • – |
2019-06-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
7,449 |
|
- |
|
| CTVA |
Corteva, Inc. |
Director |
– • – |
2019-06-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
7,359 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
officerTitle |
• – – |
2003-09-10 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
79,264 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & President, International |
• – – |
2004-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
18,000 |
97,264 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
SVP & President, International |
• – – |
2005-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,750 |
112,478 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2005-09-20 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
232,259 |
|
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2007-09-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(9,219) |
247,111 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP BMS & President WW Pharm |
• – – |
2007-09-10 |
4/A |
D |
$0.00 |
$0 |
D/D |
(7,891) |
248,439 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Operating Officer |
• – – |
2009-02-19 |
4 |
A |
$0.00 |
$0 |
D/D |
34,440 |
249,463 |
0 |
- |
|
| MJN |
Mead Johnson Nutrition Co |
Director |
– • – |
2009-12-23 |
4 |
A |
$0.00 |
$0 |
D/D |
13,609 |
19,609 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres & Chief Operating Officer |
• • – |
2009-12-23 |
4 |
S |
$0.00 |
$0 |
D/D |
(21,558) |
181,719 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres, COO & CEO Designate |
• • – |
2010-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
72,043 |
250,803 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres, COO & CEO Designate |
• • – |
2010-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(34,107) |
216,696 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres, COO & CEO Designate |
• • – |
2010-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,600 |
223,296 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
116,000 |
312,089 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(54,918) |
257,171 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
598 |
270,485 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(8,553) |
261,932 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,348 |
269,887 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,452 |
269,384 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-03-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,600 |
272,222 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-05-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,989 |
278,235 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2011-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
1,893 |
280,128 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,083 |
314,725 |
0 |
- |
|
218 Records found
|
|
Page 1 of 9 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
